Neil Gupta

Dr. Gupta’s research focus is on the treatment outcomes of chronic hepatitis C infection in Rwanda. Through the Simplifying Hepatitis C Antiviral Therapy for Elsewhere in the Developing World (SHARED) study, Dr. Gupta’s team is evaluating the safety and efficacy of direct-acting antiviral (DAA) treatment in Rwanda. The study will also evaluate the epidemiology of hepatitis C infection in Rwanda, qualitatively explore the treatment experience of individual patients, and determine risk factors for treatment failure. The study will use outcomes of the study to develop simplified models for decentralized hepatitis C care delivery and promote greater access to DAAs in low-income countries. Dr. Gupta also studies the state of health service delivery for non-communicable diseases and injuries (NCDIs) in several countries throughout sub-Saharan Africa and South Asia supporting national NCD policy, planning, and advocacy. Through the Program in Global Noncommunicable Disease and Social Change, he has led the establishment and coordination of national NCDI Poverty Commissions to research the links between NCDIs and poverty and to plan for health sector interventions to address these challenges. Dr. Gupta has previously led operational research of outcomes of a large community-based HIV care and treatment program in rural Rwanda.